Translate
HB1443 - 104th General Assembly
HEALTH CARE AVAILABILITY
Last Action
House Sponsors
Rep. Nabeela Syed, Katie Stuart, Diane Blair-Sherlock, Janet Yang Rohr, Theresa Mah, Abdelnasser Rashid, Mary Beth Canty, Kelly M. Cassidy, Will Guzzardi, Michelle Mussman, Nicolle Grasse, Norma Hernandez, Kevin John Olickal, Gregg Johnson, Camille Y. Lilly, Suzanne M. Ness, Debbie Meyers-Martin, Anne Stava, Anna Moeller, Maura Hirschauer, Dagmara Avelar, La Shawn K. Ford, Joyce Mason, Kimberly Du Buclet, Michael Crawford, Lisa Davis, Rita Mayfield, Laura Faver Dias and Emanuel "Chris" WelchHearings
Health Care Availability & Accessibility Committee Hearing Apr 15 2026 9:00AM Capitol Building Room 115 Springfield, IL - House Floor Amendment 1 - House Floor Amendment 2Health Care Availability & Accessibility Committee Hearing Apr 16 2026 9:00AM Capitol Building 115 and Virtual Room 4 Springfield, IL - House Floor Amendment 1 - House Floor Amendment 2 - House Floor Amendment 3
Statutes Amended In Order of Appearance
New Act
Synopsis As Introduced
Creates the Health Care Availability and Access Board Act. Establishes the Health Care Availability and Access Board to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains provisions concerning Board membership and terms; staff for the Board; Board meetings; circumstances under which Board members must recuse themselves; and other matters. Provides that the Board shall perform the following actions in open session: (i) deliberations on whether to subject a prescription drug product to a cost review; and (ii) any vote on whether to impose an upper payment limit on purchases, payments, and payor reimbursements of prescription drug products in the State. Permits the Board to adopt rules to implement the Act and to enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the Board. Creates the Health Care Availability and Access Stakeholder Council to provide stakeholder input to assist the Board in making decisions as required by the Act. Contains provisions concerning Council membership, member terms, and other matters. Provides that the Board shall adopt the federal Medicare Maximum Fair Price as the upper payment limit for a prescription drug product intended for use by individuals in the State. Prohibits the Board from creating an upper payment limit that is different from the Medicare Maximum Fair Price for the prescription drug product that has a Medicare Maximum Fair Price. Requires the Board to implement an upper payment limit that is the same as the Medicare Maximum Fair Price no sooner than the Medicare implementation date. Provides that Medicare Part C and D plans are not required to reimburse at the upper payment limit. Provides that the Attorney General may enforce the Act and may pursue any available remedy under State law when enforcing the Act. Effective 180 days after becoming law.
Fiscal Note (Dept. of Central Management Services)
CMS does expect a fiscal impact as a result of this proposed legislation; however, due to the nature in which prescription drug rebates are calculated on a quarterly basis in arrears and based on drug pricing, utilization, etc., the impact will ever be fluctuating. Some Medicare Maximum Fair Price drugs may result in a savings while others will result in a cost. It's impossible for CMS to quantify.
CMS does expect a fiscal impact as a result of this proposed legislation; however, due to the nature in which prescription drug rebates are calculated on a quarterly basis in arrears and based on drug pricing, utilization, etc., the impact will ever be fluctuating. Some Medicare Maximum Fair Price drugs may result in a savings while others will result in a cost. It's impossible for CMS to quantify.
Actions
| Date | Chamber | Action |
|---|---|---|
| 1/17/2025 | House | Filed with the Clerk by Rep. Nabeela Syed |
| 1/28/2025 | House | First Reading |
| 1/28/2025 | House | Referred to Rules Committee |
| 2/03/2025 | House | Added Co-Sponsor Rep. Katie Stuart |
| 2/04/2025 | House | Added Co-Sponsor Rep. Diane Blair-Sherlock |
| 2/04/2025 | House | Added Co-Sponsor Rep. Janet Yang Rohr |
| 2/11/2025 | House | Added Co-Sponsor Rep. Theresa Mah |
| 2/13/2025 | House | Added Co-Sponsor Rep. Abdelnasser Rashid |
| 2/13/2025 | House | Added Co-Sponsor Rep. Mary Beth Canty |
| 2/18/2025 | House | Added Co-Sponsor Rep. Kelly M. Cassidy |
| 2/18/2025 | House | Assigned to Health Care Availability & Accessibility Committee |
| 2/18/2025 | House | Added Co-Sponsor Rep. Will Guzzardi |
| 2/19/2025 | House | Added Co-Sponsor Rep. Michelle Mussman |
| 2/19/2025 | House | Added Co-Sponsor Rep. Nicolle Grasse |
| 2/25/2025 | House | Added Co-Sponsor Rep. Norma Hernandez |
| 2/25/2025 | House | Added Co-Sponsor Rep. Kevin John Olickal |
| 2/25/2025 | House | Added Co-Sponsor Rep. Gregg Johnson |
| 2/25/2025 | House | To Prescription Drug Affordability Board |
| 2/26/2025 | House | Added Co-Sponsor Rep. Camille Y. Lilly |
| 2/26/2025 | House | Added Co-Sponsor Rep. Suzanne M. Ness |
| 3/04/2025 | House | Added Co-Sponsor Rep. Debbie Meyers-Martin |
| 3/05/2025 | House | Added Co-Sponsor Rep. Anne Stava |
| 3/07/2025 | House | Added Co-Sponsor Rep. Anna Moeller |
| 3/13/2025 | House | Added Co-Sponsor Rep. Maura Hirschauer |
| 3/13/2025 | House | Added Co-Sponsor Rep. Dagmara Avelar |
| 3/21/2025 | House | Rule 19(a) / Re-referred to Rules Committee |
| 4/29/2025 | House | Added Co-Sponsor Rep. La Shawn K. Ford |
| 5/14/2025 | House | Added Co-Sponsor Rep. Joyce Mason |
| 2/03/2026 | House | Added Co-Sponsor Rep. Kimberly Du Buclet |
| 2/05/2026 | House | Added Co-Sponsor Rep. Michael Crawford |
| 2/05/2026 | House | Added Co-Sponsor Rep. Lisa Davis |
| 2/20/2026 | House | Added Co-Sponsor Rep. Rita Mayfield |
| 3/12/2026 | House | Assigned to Health Care Availability & Accessibility Committee |
| 3/24/2026 | House | Do Pass / Short Debate Health Care Availability & Accessibility Committee; 008-004-000 |
| 3/25/2026 | House | Placed on Calendar 2nd Reading - Short Debate |
| 4/07/2026 | House | Added Co-Sponsor Rep. Laura Faver Dias |
| 4/07/2026 | House | Added Co-Sponsor Rep. Emanuel "Chris" Welch |
| 4/07/2026 | House | Balanced Budget Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Correctional Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Fiscal Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Home Rule Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Housing Affordability Impact Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Judicial Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Land Conveyance Appraisal Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Pension Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | Racial Impact Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | State Debt Impact Note Requested by Rep. Nabeela Syed |
| 4/07/2026 | House | State Mandates Fiscal Note Requested by Rep. Nabeela Syed |
| 4/08/2026 | House | House Floor Amendment No. 1 Filed with Clerk by Rep. Nabeela Syed |
| 4/08/2026 | House | House Floor Amendment No. 1 Referred to Rules Committee |
| 4/08/2026 | House | House Floor Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee |
| 4/10/2026 | House | Second Reading - Short Debate |
| 4/10/2026 | House | Held on Calendar Order of Second Reading - Short Debate |
| 4/10/2026 | House | Fiscal Note Filed |
| 4/14/2026 | House | House Floor Amendment No. 2 Filed with Clerk by Rep. Nabeela Syed |
| 4/14/2026 | House | House Floor Amendment No. 2 Referred to Rules Committee |
| 4/14/2026 | House | House Floor Amendment No. 2 Rules Refers to Health Care Availability & Accessibility Committee |
| 4/15/2026 | House | House Floor Amendment No. 3 Filed with Clerk by Rep. Nabeela Syed |
| 4/15/2026 | House | House Floor Amendment No. 3 Referred to Rules Committee |
| 4/15/2026 | House | House Floor Amendment No. 3 Rules Refers to Health Care Availability & Accessibility Committee |
| 4/15/2026 | House | House Floor Amendment No. 4 Filed with Clerk by Rep. Nabeela Syed |
| 4/15/2026 | House | House Floor Amendment No. 4 Referred to Rules Committee |